Tectonic Therapeutic, Inc. (TECX)

♥ 589 Thanks from members

Tectonic Therapeutic, Inc. (TECX) exhibits a strong bullish institutional sentiment backed by 8 consecutive quarters of net hedge fund accumulation and a prominent Raymond James price target upgrade, contrasted by pre-revenue status and looming Phase 2 data catalysts.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

Entity & Market Metadata

Sector: Healthcare Industry: Biotechnology Founder: Gareth Morgan Founder: Peter DiSalvo Leadership: Dorottya Kőszegi (CEO) Holder: Third Rock Ventures Holder: GV Holder: Bain Capital Life Sciences GPCR-targeted therapeutics Engineered Proteins #TECX #Tectonic Therapeutic #GPCR #Cardiovascular Biotech #NASDAQ Stock